Home From Drew Altman

From Drew Altman

Drew Altman is president and chief executive officer of KFF, a position he has held for more than 30 years since founding the modern-day KFF organization in the 1990s. He is a leading expert on national health policy issues and an innovator in health journalism and the nonprofit field.

View full bio | Read Dr. Altman's Beyond the Data columns

Photo of Drew Altman

President’s Message

“KFF is an independent source of health policy research, polling, and journalism. We have four major program areas: KFF Policy; KFF Polling; KFF Health News (formerly Kaiser Health News); and KFF Social Impact Media, which conducts specialized public health information campaigns. Learn more about the organization. 

What’s unique about KFF, however, can’t be found in any description of our programs because we’re more than a sum of our parts. KFF is a one-of-a-kind information organization. Not a policy research organization. Not a polling organization. And not a news organization. But rather, a unique combination of all three. That’s the vision behind KFF, and it's this combination that allows us to leverage our combined expertise and assets to play our national role on health policy.”

Read more

Beyond the Data

In his “Beyond the Data” columns, Dr. Altman discusses what the data, polls, and journalism produced by KFF mean for policy and for people.

Drew Altman, KFF President and CEP is quoted on this card saying, "People are bewildered by a supercharged and polarized debate about vaccines and no longer know where to turn for scientific information they can rely on ... The vaccines are not the culprit—we and the state of our politics and the distrust in science and our scientific institutions they breed are."

The Problem Isn’t Trust in Vaccines, It’s That People Don’t Know Who to Trust

In a new “Beyond the Data” column, Dr. Altman analyzes years of KFF polling on vaccines in light of the current controversies about them. The real problem, he says, is not lack of public confidence in the safety of vaccines — few say they are unsafe — it’s that polarization and misinformation have eroded confidence in what’s true or not, and in scientific institutions people used to rely on for the facts.

View All Beyond the Data Columns

View the Latest: From Drew Altman

Filter

List Grid

61 - 70 of 324 Results

  • Joe Biden’s Big Lead on Health Care Issues

    From Drew Altman

    In an Axios column, Drew Altman discusses how this election year health isn’t a single issue -- but several -- and Joe Biden has the edge over President Trump on all of them, even as opposition to the ACA remains popular with Trump’s base.  

  • Black Americans Are More Skeptical of a Coronavirus Vaccine

    From Drew Altman

    Drew Altman discusses how systemic racism has led to striking levels of reluctance to get a COVID-19 vaccine among Black Americans, including those at highest risk, and the challenge it presents for ending the pandemic.

  • Drugs Aren’t the Reason the U.S. Spends So Much on Health Care

    From Drew Altman

    Drew Altman’s column in Axios: the U.S. now spends twice per capita what other wealthy countries do on health care. But while drug costs get all the time in public debate, it's hospital and outpatient spending that mostly explains the difference. And that will be impossible to take on without real pain and political risk, he says.

  • Biden vs Trump on Health With Swing Voters

    From Drew Altman

    Drawing on newly released KFF/Cook Political Report polling in key Sun Belt states, Drew Altman discusses how the 2020 election is more about President Trump but issues do matter. He says that swing voters in Florida, Arizona and North Carolina prefer Joe Biden over President Trump on more issues including health care and the coronavirus, but President Trump has the edge on their top issue, the economy. 

  • Understanding the US Failure on Coronavirus

    From Drew Altman

    For The BMJ, Drew Altman discusses two fundamental policy decisions made by the Trump administration that set the U.S. on the controversial and highly criticized course it has taken on COVID-19.

  • Pharmacies, Not the Military, Will Handle COVID-19 Vaccinations

    From Drew Altman

    President Trump has conjured up the image of a top general and the military delivering the coronavirus vaccine drawing on their vast logistical experience. In his latest Axios column, Drew Altman explains why vaccine realities will dictate that it’s much more likely to be at your local Walgreens or CVS pharmacy.

  • The Pandemic is Boosting the Public’s View of Doctors

    From Drew Altman

    In this Axios column, Drew Altman looks at how the heroic performance of the nation's doctors on the frontlines of coronavirus care and effective communication by many physician scientists on television, is shifting the public's views, with twice as many Americans now saying doctors put people ahead of profits than they did in earlier KFF polling.

  • Hotspot States See More COVID Cases in Nursing Homes

    From Drew Altman

    In his Axios column, Drew Altman discusses new data on the surge of new infections in long-term care facilities in COVID-19 hotspots. The dominant narrative about the Sunbelt surge in new cases is that the infected population is younger, but he says that’s not the whole story.